Search

everythinglearnresearchcommunity

for

Search:↓

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

ATP helps prevent skin damage from vandetanib by reducing stress.

Erythema nodosum linked to kerion can be treated effectively with antifungals and steroids to reduce scarring.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Baricitinib was effective in treating both early and late onset alopecia areata.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Adding a second method to PROTACs could improve cancer treatment.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.